Pan-cancer multi-omic model of LINE-1 activity reveals locus heterogeneity of retrotransposition efficiency

Somatic mobilization of LINE-1 (L1) has been implicated in cancer etiology. We analyzed a recent TCGA data release comprised of nearly 5000 pan-cancer paired tumor-normal whole-genome sequencing (WGS) samples and ~9000 tumor RNA samples. We developed TotalReCall an improved algorithm and pipeline fo...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Nature communications Jg. 16; H. 1; S. 2049 - 18
Hauptverfasser:	Solovyov, Alexander, Behr, Julie M., Hoyos, David, Banks, Eric, Drong, Alexander W., Thornlow, Bryan, Zhong, Jimmy Z., Garcia-Rivera, Enrique, McKerrow, Wilson, Chu, Chong, Arisdakessian, Cedric, Zaller, Dennis M., Kamihara, Junne, Diao, Liyang, Fromer, Menachem, Greenbaum, Benjamin D.
Format:	Journal Article
Sprache:	Englisch
Veröffentlicht:	London Nature Publishing Group UK 28.02.2025 Nature Publishing Group Nature Portfolio
Schlagworte:	45/43 45/91 631/114 631/67 Algorithms Cancer Gene Expression Regulation, Neoplastic Gene sequencing Heterogeneity Humanities and Social Sciences Humans Li-Fraumeni syndrome Li-Fraumeni Syndrome - genetics Loci Long Interspersed Nucleotide Elements - genetics Mathematics multidisciplinary Multiomics Mutation Neoplasms - genetics p53 Protein Retrotransposition Science Science (multidisciplinary) Tumor Suppressor Protein p53 - genetics Tumor Suppressor Protein p53 - metabolism Tumors Whole Genome Sequencing
ISSN:	2041-1723, 2041-1723
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Abstract	Somatic mobilization of LINE-1 (L1) has been implicated in cancer etiology. We analyzed a recent TCGA data release comprised of nearly 5000 pan-cancer paired tumor-normal whole-genome sequencing (WGS) samples and ~9000 tumor RNA samples. We developed TotalReCall an improved algorithm and pipeline for detection of L1 retrotransposition (RT), finding high correlation between L1 expression and “RT burden” per sample. Furthermore, we mathematically model the dual regulatory roles of p53, where mutations in TP53 disrupt regulation of both L1 expression and retrotransposition. We found those with Li-Fraumeni Syndrome (LFS) heritable TP53 pathogenic and likely pathogenic variants bear similarly high L1 activity compared to matched cancers from patients without LFS, suggesting this population be considered in attempts to target L1 therapeutically. Due to improved sensitivity, we detect over 10 genes beyond TP53 whose mutations correlate with L1, including ATRX , suggesting other, potentially targetable, mechanisms underlying L1 regulation in cancer remain to be discovered. LINE-1 activity was quantified in a large, pan-cancer dataset, finding locus-specific heterogeneity and new associations using a computational pipeline. A mathematical mediation model of p53 and L1 interactions was inferred. Somatic retrotransposition was seen in Li-Fraumeni Syndrome with heritable TP53 mutations.
AbstractList	Abstract Somatic mobilization of LINE-1 (L1) has been implicated in cancer etiology. We analyzed a recent TCGA data release comprised of nearly 5000 pan-cancer paired tumor-normal whole-genome sequencing (WGS) samples and ~9000 tumor RNA samples. We developed TotalReCall an improved algorithm and pipeline for detection of L1 retrotransposition (RT), finding high correlation between L1 expression and “RT burden” per sample. Furthermore, we mathematically model the dual regulatory roles of p53, where mutations in TP53 disrupt regulation of both L1 expression and retrotransposition. We found those with Li-Fraumeni Syndrome (LFS) heritable TP53 pathogenic and likely pathogenic variants bear similarly high L1 activity compared to matched cancers from patients without LFS, suggesting this population be considered in attempts to target L1 therapeutically. Due to improved sensitivity, we detect over 10 genes beyond TP53 whose mutations correlate with L1, including ATRX, suggesting other, potentially targetable, mechanisms underlying L1 regulation in cancer remain to be discovered. Somatic mobilization of LINE-1 (L1) has been implicated in cancer etiology. We analyzed a recent TCGA data release comprised of nearly 5000 pan-cancer paired tumor-normal whole-genome sequencing (WGS) samples and ~9000 tumor RNA samples. We developed TotalReCall an improved algorithm and pipeline for detection of L1 retrotransposition (RT), finding high correlation between L1 expression and “RT burden” per sample. Furthermore, we mathematically model the dual regulatory roles of p53, where mutations in TP53 disrupt regulation of both L1 expression and retrotransposition. We found those with Li-Fraumeni Syndrome (LFS) heritable TP53 pathogenic and likely pathogenic variants bear similarly high L1 activity compared to matched cancers from patients without LFS, suggesting this population be considered in attempts to target L1 therapeutically. Due to improved sensitivity, we detect over 10 genes beyond TP53 whose mutations correlate with L1, including ATRX, suggesting other, potentially targetable, mechanisms underlying L1 regulation in cancer remain to be discovered.LINE-1 activity was quantified in a large, pan-cancer dataset, finding locus-specific heterogeneity and new associations using a computational pipeline. A mathematical mediation model of p53 and L1 interactions was inferred. Somatic retrotransposition was seen in Li-Fraumeni Syndrome with heritable TP53 mutations. Somatic mobilization of LINE-1 (L1) has been implicated in cancer etiology. We analyzed a recent TCGA data release comprised of nearly 5000 pan-cancer paired tumor-normal whole-genome sequencing (WGS) samples and ~9000 tumor RNA samples. We developed TotalReCall an improved algorithm and pipeline for detection of L1 retrotransposition (RT), finding high correlation between L1 expression and "RT burden" per sample. Furthermore, we mathematically model the dual regulatory roles of p53, where mutations in TP53 disrupt regulation of both L1 expression and retrotransposition. We found those with Li-Fraumeni Syndrome (LFS) heritable TP53 pathogenic and likely pathogenic variants bear similarly high L1 activity compared to matched cancers from patients without LFS, suggesting this population be considered in attempts to target L1 therapeutically. Due to improved sensitivity, we detect over 10 genes beyond TP53 whose mutations correlate with L1, including ATRX, suggesting other, potentially targetable, mechanisms underlying L1 regulation in cancer remain to be discovered.Somatic mobilization of LINE-1 (L1) has been implicated in cancer etiology. We analyzed a recent TCGA data release comprised of nearly 5000 pan-cancer paired tumor-normal whole-genome sequencing (WGS) samples and ~9000 tumor RNA samples. We developed TotalReCall an improved algorithm and pipeline for detection of L1 retrotransposition (RT), finding high correlation between L1 expression and "RT burden" per sample. Furthermore, we mathematically model the dual regulatory roles of p53, where mutations in TP53 disrupt regulation of both L1 expression and retrotransposition. We found those with Li-Fraumeni Syndrome (LFS) heritable TP53 pathogenic and likely pathogenic variants bear similarly high L1 activity compared to matched cancers from patients without LFS, suggesting this population be considered in attempts to target L1 therapeutically. Due to improved sensitivity, we detect over 10 genes beyond TP53 whose mutations correlate with L1, including ATRX, suggesting other, potentially targetable, mechanisms underlying L1 regulation in cancer remain to be discovered. Somatic mobilization of LINE-1 (L1) has been implicated in cancer etiology. We analyzed a recent TCGA data release comprised of nearly 5000 pan-cancer paired tumor-normal whole-genome sequencing (WGS) samples and ~9000 tumor RNA samples. We developed TotalReCall an improved algorithm and pipeline for detection of L1 retrotransposition (RT), finding high correlation between L1 expression and "RT burden" per sample. Furthermore, we mathematically model the dual regulatory roles of p53, where mutations in TP53 disrupt regulation of both L1 expression and retrotransposition. We found those with Li-Fraumeni Syndrome (LFS) heritable TP53 pathogenic and likely pathogenic variants bear similarly high L1 activity compared to matched cancers from patients without LFS, suggesting this population be considered in attempts to target L1 therapeutically. Due to improved sensitivity, we detect over 10 genes beyond TP53 whose mutations correlate with L1, including ATRX, suggesting other, potentially targetable, mechanisms underlying L1 regulation in cancer remain to be discovered. Somatic mobilization of LINE-1 (L1) has been implicated in cancer etiology. We analyzed a recent TCGA data release comprised of nearly 5000 pan-cancer paired tumor-normal whole-genome sequencing (WGS) samples and ~9000 tumor RNA samples. We developed TotalReCall an improved algorithm and pipeline for detection of L1 retrotransposition (RT), finding high correlation between L1 expression and “RT burden” per sample. Furthermore, we mathematically model the dual regulatory roles of p53, where mutations in TP53 disrupt regulation of both L1 expression and retrotransposition. We found those with Li-Fraumeni Syndrome (LFS) heritable TP53 pathogenic and likely pathogenic variants bear similarly high L1 activity compared to matched cancers from patients without LFS, suggesting this population be considered in attempts to target L1 therapeutically. Due to improved sensitivity, we detect over 10 genes beyond TP53 whose mutations correlate with L1, including ATRX , suggesting other, potentially targetable, mechanisms underlying L1 regulation in cancer remain to be discovered. LINE-1 activity was quantified in a large, pan-cancer dataset, finding locus-specific heterogeneity and new associations using a computational pipeline. A mathematical mediation model of p53 and L1 interactions was inferred. Somatic retrotransposition was seen in Li-Fraumeni Syndrome with heritable TP53 mutations. Somatic mobilization of LINE-1 (L1) has been implicated in cancer etiology. We analyzed a recent TCGA data release comprised of nearly 5000 pan-cancer paired tumor-normal whole-genome sequencing (WGS) samples and ~9000 tumor RNA samples. We developed TotalReCall an improved algorithm and pipeline for detection of L1 retrotransposition (RT), finding high correlation between L1 expression and “RT burden” per sample. Furthermore, we mathematically model the dual regulatory roles of p53, where mutations in TP53 disrupt regulation of both L1 expression and retrotransposition. We found those with Li-Fraumeni Syndrome (LFS) heritable TP53 pathogenic and likely pathogenic variants bear similarly high L1 activity compared to matched cancers from patients without LFS, suggesting this population be considered in attempts to target L1 therapeutically. Due to improved sensitivity, we detect over 10 genes beyond TP53 whose mutations correlate with L1, including ATRX, suggesting other, potentially targetable, mechanisms underlying L1 regulation in cancer remain to be discovered. LINE-1 activity was quantified in a large, pan-cancer dataset, finding locus-specific heterogeneity and new associations using a computational pipeline. A mathematical mediation model of p53 and L1 interactions was inferred. Somatic retrotransposition was seen in Li-Fraumeni Syndrome with heritable TP53 mutations.
ArticleNumber	2049
Author	Chu, Chong Zaller, Dennis M. Behr, Julie M. Thornlow, Bryan Banks, Eric Hoyos, David Arisdakessian, Cedric Diao, Liyang Garcia-Rivera, Enrique McKerrow, Wilson Greenbaum, Benjamin D. Fromer, Menachem Zhong, Jimmy Z. Kamihara, Junne Solovyov, Alexander Drong, Alexander W.
Author_xml	– sequence: 1 givenname: Alexander surname: Solovyov fullname: Solovyov, Alexander email: solovyova@mskcc.org organization: Halvorsen Center for Computational Oncology, Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center – sequence: 2 givenname: Julie M. orcidid: 0000-0001-8601-4902 surname: Behr fullname: Behr, Julie M. organization: ROME Therapeutics, Inc – sequence: 3 givenname: David surname: Hoyos fullname: Hoyos, David organization: Halvorsen Center for Computational Oncology, Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center – sequence: 4 givenname: Eric surname: Banks fullname: Banks, Eric organization: ROME Therapeutics, Inc., Acorn Biosciences – sequence: 5 givenname: Alexander W. surname: Drong fullname: Drong, Alexander W. organization: ROME Therapeutics, Inc – sequence: 6 givenname: Bryan surname: Thornlow fullname: Thornlow, Bryan organization: ROME Therapeutics, Inc – sequence: 7 givenname: Jimmy Z. surname: Zhong fullname: Zhong, Jimmy Z. organization: ROME Therapeutics, Inc – sequence: 8 givenname: Enrique surname: Garcia-Rivera fullname: Garcia-Rivera, Enrique organization: ROME Therapeutics, Inc – sequence: 9 givenname: Wilson surname: McKerrow fullname: McKerrow, Wilson organization: ROME Therapeutics, Inc – sequence: 10 givenname: Chong orcidid: 0000-0002-0796-2339 surname: Chu fullname: Chu, Chong organization: ROME Therapeutics, Inc – sequence: 11 givenname: Cedric orcidid: 0000-0001-5255-0942 surname: Arisdakessian fullname: Arisdakessian, Cedric organization: ROME Therapeutics, Inc – sequence: 12 givenname: Dennis M. surname: Zaller fullname: Zaller, Dennis M. organization: ROME Therapeutics, Inc – sequence: 13 givenname: Junne orcidid: 0000-0002-2852-7387 surname: Kamihara fullname: Kamihara, Junne organization: Division of Hematology/Oncology, Boston Children’s Hospital, Department of Pediatric Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Division of Population Sciences, Dana-Farber Cancer Institute, Harvard Medical School – sequence: 14 givenname: Liyang surname: Diao fullname: Diao, Liyang organization: ROME Therapeutics, Inc – sequence: 15 givenname: Menachem orcidid: 0000-0003-3749-4342 surname: Fromer fullname: Fromer, Menachem organization: ROME Therapeutics, Inc – sequence: 16 givenname: Benjamin D. orcidid: 0000-0001-6153-8793 surname: Greenbaum fullname: Greenbaum, Benjamin D. email: greenbab@mskcc.org organization: Halvorsen Center for Computational Oncology, Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, Physiology, Biophysics & Systems Biology, Weill Cornell Medical College
BackLink	https://www.ncbi.nlm.nih.gov/pubmed/40021663$$D View this record in MEDLINE/PubMed
BookMark	eNp9Uk1v1DAQjVAR_aB_gAOKxIVLwOOPODkhVBW60go49G45zmTrJbEX21lp_z3e3RbaHuqLR573np5n3nlx4rzDongH5BMQ1nyOHHgtK0JFJSSVUMGr4owSngtJ2cmj-rS4jHFN8mEtNJy_KU45IRTqmp0Vv39pVxntDIZymsdkKz9ZU06-x7H0Q7lc_LiuoNQm2a1NuzLgFvUYy9GbOZZ3mDD4FTrc9zI8YAo-Be3ixkebrHclDoM1Fp3ZvS1eD5mLl_f3RXH77fr26qZa_vy-uPq6rIzgkCrGtUCgUgvTtW1X9z0ntOsIr3vSoeEEmeCcABkY1nVvOiFBNkMvWt6SGthFsTjK9l6v1SbYSYed8tqqw4MPK6VDsmZEJbCTujZGDD3htINWg2lADLJlNaGSZK0vR63N3E3YG3T5c-MT0acdZ-_Uym8VQCMBaJMVPt4rBP9nxpjUZKPBcdQO_RwVyyuSUhKoM_TDM-jaz8HlUR1QrGVNs0e9f2zpn5eHnWZAcwSY4GMMOChjk97vIju0owKi9glSxwSpnCB1SJDaj44-oz6ov0hiR1LMYLfC8N_2C6y_KWnYLg
CitedBy_id	crossref_primary_10_3390_life15091338 crossref_primary_10_1186_s13100_025_00368_7 crossref_primary_10_1002_cnr2_70325 crossref_primary_10_1016_j_tig_2025_08_002
Cites_doi	10.1126/science.1200801 10.1093/nar/gkac128 10.1126/scisignal.2004088 10.1038/nrc.2017.35 10.1038/cdd.2017.171 10.1016/j.cell.2022.08.004 10.1126/scitranslmed.abl6057 10.1038/s41586-023-06947-z 10.1016/j.ajpath.2014.01.007 10.1126/science.1251343 10.1016/j.cell.2015.07.011 10.1016/j.celrep.2018.03.042 10.1186/s13148-022-01386-5 10.1101/gr.231837.117 10.1101/gr.163659.113 10.1093/bioinformatics/btz724 10.1126/science.abf7117 10.1101/gad.343186.120 10.1038/s41588-019-0562-0 10.1101/gr.218032.116 10.1073/pnas.2115999119 10.1016/j.cell.2013.02.032 10.1093/nar/gkac013 10.1038/onc.2009.246 10.1534/genetics.119.302601 10.1198/000313004X946 10.1016/j.cell.2012.04.026 10.1093/bioinformatics/btab135 10.1038/sdata.2016.25 10.1016/j.neuron.2023.02.007 10.7554/eLife.13926 10.1101/gad.266098.115 10.1016/j.cell.2012.04.019 10.1073/pnas.1517584112 10.1126/science.1905840 10.1038/s41594-020-0372-1 10.1073/pnas.0831042100 10.1056/NEJMra1510092 10.1007/s12041-013-0212-8 10.1016/j.cell.2010.05.021 10.1038/nsmb1107 10.1126/science.abk3112 10.1073/pnas.1216922110 10.1038/ng.368 10.1101/gr.205701 10.1038/s41467-021-24041-8 10.1038/nrg928 10.1016/j.cell.2015.07.056 10.1158/2159-8290.CD-12-0095 10.1186/1476-4598-3-12 10.1016/j.celrep.2013.04.012 10.1073/pnas.0601324103 10.1016/j.cell.2018.03.039 10.1002/humu.24152
ContentType	Journal Article
Copyright	The Author(s) 2025 corrected publication 2025 2025. The Author(s). Copyright Nature Publishing Group 2025 The Author(s) 2025 2025
Copyright_xml	– notice: The Author(s) 2025 corrected publication 2025 – notice: 2025. The Author(s). – notice: Copyright Nature Publishing Group 2025 – notice: The Author(s) 2025 2025
DBID	C6C AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7QL 7QP 7QR 7SN 7SS 7ST 7T5 7T7 7TM 7TO 7X7 7XB 88E 8AO 8FD 8FE 8FG 8FH 8FI 8FJ 8FK ABUWG AEUYN AFKRA ARAPS AZQEC BBNVY BENPR BGLVJ BHPHI C1K CCPQU DWQXO FR3 FYUFA GHDGH GNUQQ H94 HCIFZ K9. LK8 M0S M1P M7P P5Z P62 P64 PHGZM PHGZT PIMPY PJZUB PKEHL PPXIY PQEST PQGLB PQQKQ PQUKI PRINS RC3 SOI 7X8 5PM DOA
DOI	10.1038/s41467-025-57271-1
DatabaseName	Springer Nature OA Free Journals CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Bacteriology Abstracts (Microbiology B) Calcium & Calcified Tissue Abstracts Chemoreception Abstracts Ecology Abstracts Entomology Abstracts (Full archive) Environment Abstracts Immunology Abstracts Industrial and Applied Microbiology Abstracts (Microbiology A) Nucleic Acids Abstracts Oncogenes and Growth Factors Abstracts Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) ProQuest Pharma Collection Technology Research Database ProQuest SciTech Collection ProQuest Technology Collection ProQuest Natural Science Collection ProQuest Hospital Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) One Sustainability ProQuest Central UK/Ireland Advanced Technologies & Computer Science Collection ProQuest Central Essentials - QC ProQuest SciTech Premium Collection Natural Science Collection Biological Science Collection ProQuest Central Technology collection Natural Science Collection Environmental Sciences and Pollution Management ProQuest One Community College ProQuest Central Engineering Research Database Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student AIDS and Cancer Research Abstracts SciTech Premium Collection ProQuest Health & Medical Complete (Alumni) Biological Sciences ProQuest Health & Medical Collection Medical Database Biological Science Database Advanced Technologies & Aerospace Database ProQuest Advanced Technologies & Aerospace Collection Biotechnology and BioEngineering Abstracts ProQuest Central Premium ProQuest One Academic (New) Publicly Available Content Database ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) One Applied & Life Sciences ProQuest One Academic (retired) ProQuest One Academic UKI Edition ProQuest Central China Genetics Abstracts Environment Abstracts MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals
DatabaseTitle	CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Publicly Available Content Database ProQuest Central Student Oncogenes and Growth Factors Abstracts ProQuest Advanced Technologies & Aerospace Collection ProQuest Central Essentials Nucleic Acids Abstracts SciTech Premium Collection ProQuest Central China Environmental Sciences and Pollution Management ProQuest One Applied & Life Sciences ProQuest One Sustainability Health Research Premium Collection Natural Science Collection Health & Medical Research Collection Biological Science Collection Chemoreception Abstracts Industrial and Applied Microbiology Abstracts (Microbiology A) ProQuest Central (New) ProQuest Medical Library (Alumni) Advanced Technologies & Aerospace Collection ProQuest Biological Science Collection ProQuest One Academic Eastern Edition ProQuest Hospital Collection ProQuest Technology Collection Health Research Premium Collection (Alumni) Biological Science Database Ecology Abstracts ProQuest Hospital Collection (Alumni) Biotechnology and BioEngineering Abstracts Entomology Abstracts ProQuest Health & Medical Complete ProQuest One Academic UKI Edition Engineering Research Database ProQuest One Academic Calcium & Calcified Tissue Abstracts ProQuest One Academic (New) Technology Collection Technology Research Database ProQuest One Academic Middle East (New) ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing ProQuest Natural Science Collection ProQuest Pharma Collection ProQuest Central ProQuest Health & Medical Research Collection Genetics Abstracts Health and Medicine Complete (Alumni Edition) ProQuest Central Korea Bacteriology Abstracts (Microbiology B) AIDS and Cancer Research Abstracts ProQuest SciTech Collection Advanced Technologies & Aerospace Database ProQuest Medical Library Immunology Abstracts Environment Abstracts ProQuest Central (Alumni) MEDLINE - Academic
DatabaseTitleList	Publicly Available Content Database MEDLINE - Academic MEDLINE CrossRef
Database_xml	– sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: PIMPY name: Publicly Available Content Database url: http://search.proquest.com/publiccontent sourceTypes: Aggregation Database
DeliveryMethod	fulltext_linktorsrc
Discipline	Biology Mathematics
EISSN	2041-1723
EndPage	18
ExternalDocumentID	oai_doaj_org_article_5eb7a6cc5fd042b19a1c815f79360270 PMC11871128 40021663 10_1038_s41467_025_57271_1
Genre	Journal Article
GrantInformation_xml	– fundername: U.S. Department of Health & Human Services \| NIH \| National Cancer Institute (NCI) grantid: P30CA008748; R01AI081848; U01CA228963 funderid: https://doi.org/10.13039/100000054 – fundername: NIAID NIH HHS grantid: R01 AI081848 – fundername: U.S. Department of Health & Human Services \| NIH \| National Cancer Institute (NCI) grantid: R01AI081848 – fundername: NCI NIH HHS grantid: R01 CA240924 – fundername: U.S. Department of Health & Human Services \| NIH \| National Cancer Institute (NCI) grantid: P30CA008748 – fundername: NCI NIH HHS grantid: P30 CA008748 – fundername: NCI NIH HHS grantid: U01 CA228963 – fundername: U.S. Department of Health & Human Services \| NIH \| National Cancer Institute (NCI) grantid: U01CA228963
GroupedDBID	--- 0R~ 39C 53G 5VS 70F 7X7 88E 8AO 8FE 8FG 8FH 8FI 8FJ AAHBH AAJSJ AASML ABUWG ACGFO ACGFS ACIWK ACMJI ACPRK ADBBV ADFRT ADMLS ADRAZ AENEX AEUYN AFKRA AFRAH AHMBA AJTQC ALIPV ALMA_UNASSIGNED_HOLDINGS AMTXH AOIJS ARAPS ASPBG AVWKF AZFZN BBNVY BCNDV BENPR BGLVJ BHPHI BPHCQ BVXVI C6C CCPQU DIK EBLON EBS EE. EMOBN F5P FEDTE FYUFA GROUPED_DOAJ HCIFZ HMCUK HVGLF HYE HZ~ KQ8 LGEZI LK8 LOTEE M1P M7P M~E NADUK NAO NXXTH O9- OK1 P2P P62 PHGZT PIMPY PQQKQ PROAC PSQYO RNS RNT RNTTT RPM SV3 TSG UKHRP AAYXX AFFHD CITATION PHGZM PJZUB PPXIY PQGLB SNYQT CGR CUY CVF ECM EIF NPM 3V. 7QL 7QP 7QR 7SN 7SS 7ST 7T5 7T7 7TM 7TO 7XB 8FD 8FK AZQEC C1K DWQXO FR3 GNUQQ H94 K9. M48 P64 PKEHL PQEST PQUKI PRINS RC3 SOI 7X8 PUEGO 5PM
ID	FETCH-LOGICAL-c541t-34a5e127a5cb99b6dd402bb046d0bec40e3544010f3e66dcb57178fd59490613
IEDL.DBID	P5Z
ISICitedReferencesCount	4
ISICitedReferencesURI	http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=001435592900036&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN	2041-1723
IngestDate	Fri Oct 03 12:52:59 EDT 2025 Tue Nov 04 02:05:13 EST 2025 Thu Sep 04 15:39:59 EDT 2025 Tue Oct 07 07:04:00 EDT 2025 Mon May 12 02:38:46 EDT 2025 Sat Nov 29 08:05:15 EST 2025 Tue Nov 18 21:04:17 EST 2025 Wed Mar 26 01:23:20 EDT 2025
IsDoiOpenAccess	true
IsOpenAccess	true
IsPeerReviewed	true
IsScholarly	true
Issue	1
Language	English
License	2025. The Author(s). Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
LinkModel	DirectLink
MergedId	FETCHMERGED-LOGICAL-c541t-34a5e127a5cb99b6dd402bb046d0bec40e3544010f3e66dcb57178fd59490613
Notes	ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23
ORCID	0000-0001-5255-0942 0000-0002-0796-2339 0000-0003-3749-4342 0000-0001-6153-8793 0000-0002-2852-7387 0000-0001-8601-4902
OpenAccessLink	https://www.proquest.com/docview/3172393886?pq-origsite=%requestingapplication%
PMID	40021663
PQID	3172393886
PQPubID	546298
PageCount	18
ParticipantIDs	doaj_primary_oai_doaj_org_article_5eb7a6cc5fd042b19a1c815f79360270 pubmedcentral_primary_oai_pubmedcentral_nih_gov_11871128 proquest_miscellaneous_3172777016 proquest_journals_3172393886 pubmed_primary_40021663 crossref_citationtrail_10_1038_s41467_025_57271_1 crossref_primary_10_1038_s41467_025_57271_1 springer_journals_10_1038_s41467_025_57271_1
PublicationCentury	2000
PublicationDate	2025-02-28
PublicationDateYYYYMMDD	2025-02-28
PublicationDate_xml	– month: 02 year: 2025 text: 2025-02-28 day: 28
PublicationDecade	2020
PublicationPlace	London
PublicationPlace_xml	– name: London – name: England
PublicationTitle	Nature communications
PublicationTitleAbbrev	Nat Commun
PublicationTitleAlternate	Nat Commun
PublicationYear	2025
Publisher	Nature Publishing Group UK Nature Publishing Group Nature Portfolio
Publisher_xml	– name: Nature Publishing Group UK – name: Nature Publishing Group – name: Nature Portfolio
References	JM Zook (57271_CR35) 2016; 3 DA Kulpa (57271_CR37) 2006; 13 DT Ting (57271_CR7) 2011; 331 E Cerami (57271_CR41) 2012; 2 MC Seleme (57271_CR20) 2006; 103 AM Kaiser (57271_CR48) 2018; 25 EJ Gardner (57271_CR17) 2017; 27 57271_CR52 M Casarotto (57271_CR31) 2022; 14 57271_CR14 CR Beck (57271_CR25) 2010; 141 F Della Valle (57271_CR43) 2022; 14 EM Adney (57271_CR45) 2019; 213 A Wylie (57271_CR40) 2016; 30 A Solovyov (57271_CR9) 2018; 23 T Li (57271_CR47) 2012; 149 S Magadum (57271_CR23) 2013; 92 GJ Faulkner (57271_CR51) 2009; 41 ET Baldwin (57271_CR44) 2024; 626 EM Ostertag (57271_CR34) 2001; 11 57271_CR3 HH Kazazian Jr. (57271_CR1) 2017; 377 B Brouha (57271_CR24) 2003; 100 B Freeman (57271_CR21) 2022; 50 57271_CR26 GJ Faulkner (57271_CR53) 2023; 111 A Haoudi (57271_CR29) 2004; 2004 M Byrska-Bishop (57271_CR27) 2022; 185 E Helman (57271_CR16) 2014; 24 H Jung (57271_CR18) 2018; 28 VE Prince (57271_CR22) 2002; 3 W McKerrow (57271_CR28) 2020; 36 A Tanne (57271_CR12) 2015; 112 Y Niu (57271_CR36) 2022; 50 57271_CR32 K-L Huang (57271_CR55) 2018; 173 KI Leonova (57271_CR4) 2013; 110 M Hollstein (57271_CR38) 1991; 253 CR Harris (57271_CR39) 2009; 28 SJ Hoyt (57271_CR2) 2022; 376 KB Chiappinelli (57271_CR8) 2015; 162 LJ Valente (57271_CR46) 2013; 3 C Chu (57271_CR19) 2021; 12 D Roulois (57271_CR10) 2015; 162 B Rodriguez-Martin (57271_CR11) 2020; 52 A Graubert (57271_CR54) 2021; 37 KH Burns (57271_CR6) 2017; 17 D Ardeljan (57271_CR50) 2020; 27 L Menendez (57271_CR5) 2004; 3 KH Burns (57271_CR13) 2012; 149 JMC Tubio (57271_CR15) 2014; 345 N Rodic (57271_CR30) 2014; 184 B Tiwari (57271_CR33) 2020; 34 J Gao (57271_CR42) 2013; 6 CAL Fortuno (57271_CR56) 2021; 42 S Menard (57271_CR57) 2004; 58 R Shukla (57271_CR49) 2013; 153 40128545 - Nat Commun. 2025 Mar 24;16(1):2870. doi: 10.1038/s41467-025-58288-2.
References_xml	– volume: 331 start-page: 593 year: 2011 ident: 57271_CR7 publication-title: Science doi: 10.1126/science.1200801 – volume: 50 start-page: 2493 year: 2022 ident: 57271_CR36 publication-title: Nucleic Acids Res. doi: 10.1093/nar/gkac128 – volume: 6 start-page: pl1 year: 2013 ident: 57271_CR42 publication-title: Sci. Signal. doi: 10.1126/scisignal.2004088 – volume: 17 start-page: 415 year: 2017 ident: 57271_CR6 publication-title: Nat. Rev. Cancer doi: 10.1038/nrc.2017.35 – volume: 25 start-page: 93 year: 2018 ident: 57271_CR48 publication-title: Cell Death Differ. doi: 10.1038/cdd.2017.171 – volume: 185 start-page: 3426 year: 2022 ident: 57271_CR27 publication-title: Cell doi: 10.1016/j.cell.2022.08.004 – volume: 14 start-page: eabl6057 year: 2022 ident: 57271_CR43 publication-title: Sci. Transl. Med. doi: 10.1126/scitranslmed.abl6057 – volume: 626 start-page: 194 year: 2024 ident: 57271_CR44 publication-title: Nature doi: 10.1038/s41586-023-06947-z – volume: 184 start-page: 1280 year: 2014 ident: 57271_CR30 publication-title: Am. J. Pathol. doi: 10.1016/j.ajpath.2014.01.007 – volume: 345 start-page: 1251343 year: 2014 ident: 57271_CR15 publication-title: Science doi: 10.1126/science.1251343 – volume: 162 start-page: 974 year: 2015 ident: 57271_CR8 publication-title: Cell doi: 10.1016/j.cell.2015.07.011 – volume: 23 start-page: 512 year: 2018 ident: 57271_CR9 publication-title: Cell Rep. doi: 10.1016/j.celrep.2018.03.042 – volume: 14 year: 2022 ident: 57271_CR31 publication-title: Clin. Epigenetics doi: 10.1186/s13148-022-01386-5 – volume: 28 start-page: 1136 year: 2018 ident: 57271_CR18 publication-title: Genome Res. doi: 10.1101/gr.231837.117 – volume: 24 start-page: 1053 year: 2014 ident: 57271_CR16 publication-title: Genome Res. doi: 10.1101/gr.163659.113 – volume: 2004 start-page: 185 year: 2004 ident: 57271_CR29 publication-title: J. Biomed. Biotechnol. – volume: 36 start-page: 1167 year: 2020 ident: 57271_CR28 publication-title: Bioinformatics doi: 10.1093/bioinformatics/btz724 – ident: 57271_CR26 doi: 10.1126/science.abf7117 – volume: 34 start-page: 1439 year: 2020 ident: 57271_CR33 publication-title: Genes Dev. doi: 10.1101/gad.343186.120 – volume: 52 start-page: 306 year: 2020 ident: 57271_CR11 publication-title: Nat. Genet. doi: 10.1038/s41588-019-0562-0 – volume: 27 start-page: 1916 year: 2017 ident: 57271_CR17 publication-title: Genome Res. doi: 10.1101/gr.218032.116 – ident: 57271_CR32 doi: 10.1073/pnas.2115999119 – volume: 153 start-page: 101 year: 2013 ident: 57271_CR49 publication-title: Cell doi: 10.1016/j.cell.2013.02.032 – volume: 50 start-page: 1888 year: 2022 ident: 57271_CR21 publication-title: Nucleic Acids Res. doi: 10.1093/nar/gkac013 – volume: 28 start-page: 3857 year: 2009 ident: 57271_CR39 publication-title: Oncogene doi: 10.1038/onc.2009.246 – volume: 213 start-page: 1401 year: 2019 ident: 57271_CR45 publication-title: Genetics doi: 10.1534/genetics.119.302601 – volume: 58 start-page: 218 year: 2004 ident: 57271_CR57 publication-title: Am. Stat. doi: 10.1198/000313004X946 – volume: 149 start-page: 1269 year: 2012 ident: 57271_CR47 publication-title: Cell doi: 10.1016/j.cell.2012.04.026 – volume: 37 start-page: 3048 year: 2021 ident: 57271_CR54 publication-title: Bioinformatics doi: 10.1093/bioinformatics/btab135 – volume: 3 year: 2016 ident: 57271_CR35 publication-title: Sci. Data doi: 10.1038/sdata.2016.25 – volume: 111 start-page: 610 year: 2023 ident: 57271_CR53 publication-title: Neuron doi: 10.1016/j.neuron.2023.02.007 – ident: 57271_CR14 doi: 10.7554/eLife.13926 – volume: 30 start-page: 64 year: 2016 ident: 57271_CR40 publication-title: Genes Dev. doi: 10.1101/gad.266098.115 – volume: 149 start-page: 740 year: 2012 ident: 57271_CR13 publication-title: Cell doi: 10.1016/j.cell.2012.04.019 – volume: 112 start-page: 15154 year: 2015 ident: 57271_CR12 publication-title: Proc. Natl Acad. Sci. USA doi: 10.1073/pnas.1517584112 – volume: 253 start-page: 49 year: 1991 ident: 57271_CR38 publication-title: Science doi: 10.1126/science.1905840 – volume: 27 start-page: 168 year: 2020 ident: 57271_CR50 publication-title: Nat. Struct. Mol. Biol. doi: 10.1038/s41594-020-0372-1 – volume: 100 start-page: 5280 year: 2003 ident: 57271_CR24 publication-title: Proc. Natl Acad. Sci. USA doi: 10.1073/pnas.0831042100 – volume: 377 start-page: 361 year: 2017 ident: 57271_CR1 publication-title: N. Engl. J. Med. doi: 10.1056/NEJMra1510092 – volume: 92 start-page: 155 year: 2013 ident: 57271_CR23 publication-title: J. Genet. doi: 10.1007/s12041-013-0212-8 – volume: 141 start-page: 1159 year: 2010 ident: 57271_CR25 publication-title: Cell doi: 10.1016/j.cell.2010.05.021 – volume: 13 start-page: 655 year: 2006 ident: 57271_CR37 publication-title: Nat. Struct. Mol. Biol. doi: 10.1038/nsmb1107 – volume: 376 start-page: eabk3112 year: 2022 ident: 57271_CR2 publication-title: Science doi: 10.1126/science.abk3112 – volume: 110 start-page: E89 year: 2013 ident: 57271_CR4 publication-title: Proc. Natl Acad. Sci. USA doi: 10.1073/pnas.1216922110 – volume: 41 start-page: 563 year: 2009 ident: 57271_CR51 publication-title: Nat. Genet doi: 10.1038/ng.368 – volume: 11 start-page: 2059 year: 2001 ident: 57271_CR34 publication-title: Genome Res. doi: 10.1101/gr.205701 – volume: 12 year: 2021 ident: 57271_CR19 publication-title: Nat. Commun. doi: 10.1038/s41467-021-24041-8 – volume: 3 start-page: 827 year: 2002 ident: 57271_CR22 publication-title: Nat. Rev. Genet. doi: 10.1038/nrg928 – volume: 162 start-page: 961 year: 2015 ident: 57271_CR10 publication-title: Cell doi: 10.1016/j.cell.2015.07.056 – volume: 2 start-page: 401 year: 2012 ident: 57271_CR41 publication-title: Cancer Discov. doi: 10.1158/2159-8290.CD-12-0095 – ident: 57271_CR3 – volume: 3 year: 2004 ident: 57271_CR5 publication-title: Mol. Cancer doi: 10.1186/1476-4598-3-12 – volume: 3 start-page: 1339 year: 2013 ident: 57271_CR46 publication-title: Cell Rep. doi: 10.1016/j.celrep.2013.04.012 – volume: 103 start-page: 6611 year: 2006 ident: 57271_CR20 publication-title: Proc. Natl Acad. Sci. USA doi: 10.1073/pnas.0601324103 – ident: 57271_CR52 – volume: 173 start-page: 355 year: 2018 ident: 57271_CR55 publication-title: Cell doi: 10.1016/j.cell.2018.03.039 – volume: 42 start-page: 223 year: 2021 ident: 57271_CR56 publication-title: Hum. Mutat. doi: 10.1002/humu.24152 – reference: 40128545 - Nat Commun. 2025 Mar 24;16(1):2870. doi: 10.1038/s41467-025-58288-2.
SSID	ssj0000391844
Score	2.4936492
Snippet	Somatic mobilization of LINE-1 (L1) has been implicated in cancer etiology. We analyzed a recent TCGA data release comprised of nearly 5000 pan-cancer paired... Abstract Somatic mobilization of LINE-1 (L1) has been implicated in cancer etiology. We analyzed a recent TCGA data release comprised of nearly 5000 pan-cancer...
SourceID	doaj pubmedcentral proquest pubmed crossref springer
SourceType	Open Website Open Access Repository Aggregation Database Index Database Enrichment Source Publisher
StartPage	2049
SubjectTerms	45/43 45/91 631/114 631/67 Algorithms Cancer Gene Expression Regulation, Neoplastic Gene sequencing Heterogeneity Humanities and Social Sciences Humans Li-Fraumeni syndrome Li-Fraumeni Syndrome - genetics Loci Long Interspersed Nucleotide Elements - genetics Mathematics multidisciplinary Multiomics Mutation Neoplasms - genetics p53 Protein Retrotransposition Science Science (multidisciplinary) Tumor Suppressor Protein p53 - genetics Tumor Suppressor Protein p53 - metabolism Tumors Whole Genome Sequencing
SummonAdditionalLinks	– databaseName: DOAJ Directory of Open Access Journals dbid: DOA link: http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwELZQVSQuiJZXoCAjcQOr8dpO7COgVkVCqx566M3yK2oFSqpsFol_z4ydXbo8L1xjJ7I8nzMz8sz3EfI61d4Z3klWG--YbERkDrw807HxjgfZOlfEJtrlUl9emvNbUl9YE1bogcvGHavkW9eEoLoI-PLcwBc0Vx3gqoGUKmfrEPXcSqbyP1gYSF3k3CVTC328kvmfgOqtCnw2Z3zHE2XC_t9Fmb8WS_50Y5od0ekDcn-OIOm7svIDcif1h-Ru0ZT89pB8Pnc9C2jLkeZqQYZ9xzQr3tCho58-Lk8Yp9jPgLIRFCmcAIIUnNp6Ra-wOmYAUCUcg-ljmsZhKgzopbyLpsw6gS2bj8jF6cnFhzM2KyqwoCSfmJBOJb5onQreGN_ECOmj95AjxxqMKesklISMq-5EapoYvIJsT3dRGWnQ8T8me_3Qp6eEChWl4l6mduFk7ILhokWuPo8UeUKIivDN5tows42j6MUXm2-9hbbFIBYMYrNBLK_Im-07N4Vr46-z36PNtjORJzs_APTYGT32X-ipyNHG4nY-vCsLIRUSw2ndVOTVdhiOHd6luD4N6zKnbVsImCvypABkuxKJgRNEchXRO9DZWeruSH99lam9UfwdImBdkbcblP1Y15_34tn_2Ivn5N4Cj0fu1z8ie9O4Ti_Ifvg6Xa_Gl_l8fQcOyyav priority: 102 providerName: Directory of Open Access Journals
Title	Pan-cancer multi-omic model of LINE-1 activity reveals locus heterogeneity of retrotransposition efficiency
URI	https://link.springer.com/article/10.1038/s41467-025-57271-1 https://www.ncbi.nlm.nih.gov/pubmed/40021663 https://www.proquest.com/docview/3172393886 https://www.proquest.com/docview/3172777016 https://pubmed.ncbi.nlm.nih.gov/PMC11871128 https://doaj.org/article/5eb7a6cc5fd042b19a1c815f79360270
Volume	16
WOSCitedRecordID	wos001435592900036&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText	1
inHoldings	1
isFullTextHit
isPrint
journalDatabaseRights	– providerCode: PRVAON databaseName: DOAJ Directory of Open Access Journals customDbUrl: eissn: 2041-1723 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0000391844 issn: 2041-1723 databaseCode: DOA dateStart: 20150101 isFulltext: true titleUrlDefault: https://www.doaj.org/ providerName: Directory of Open Access Journals – providerCode: PRVHPJ databaseName: ROAD: Directory of Open Access Scholarly Resources customDbUrl: eissn: 2041-1723 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0000391844 issn: 2041-1723 databaseCode: M~E dateStart: 20100101 isFulltext: true titleUrlDefault: https://road.issn.org providerName: ISSN International Centre – providerCode: PRVPQU databaseName: Advanced Technologies & Aerospace Database customDbUrl: eissn: 2041-1723 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0000391844 issn: 2041-1723 databaseCode: P5Z dateStart: 20100101 isFulltext: true titleUrlDefault: https://search.proquest.com/hightechjournals providerName: ProQuest – providerCode: PRVPQU databaseName: Biological Science Database customDbUrl: eissn: 2041-1723 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0000391844 issn: 2041-1723 databaseCode: M7P dateStart: 20100101 isFulltext: true titleUrlDefault: http://search.proquest.com/biologicalscijournals providerName: ProQuest – providerCode: PRVPQU databaseName: Health & Medical Collection customDbUrl: eissn: 2041-1723 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0000391844 issn: 2041-1723 databaseCode: 7X7 dateStart: 20100101 isFulltext: true titleUrlDefault: https://search.proquest.com/healthcomplete providerName: ProQuest – providerCode: PRVPQU databaseName: ProQuest Central customDbUrl: eissn: 2041-1723 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0000391844 issn: 2041-1723 databaseCode: BENPR dateStart: 20100101 isFulltext: true titleUrlDefault: https://www.proquest.com/central providerName: ProQuest – providerCode: PRVPQU databaseName: Publicly Available Content Database customDbUrl: eissn: 2041-1723 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0000391844 issn: 2041-1723 databaseCode: PIMPY dateStart: 20100101 isFulltext: true titleUrlDefault: http://search.proquest.com/publiccontent providerName: ProQuest
link	http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Lb9QwEB7RFqRy4FFegbIyEjewGq_t2DkhiraiEl1FqIeFS2QnTluBkjbZReLf43GyqZZHL1xyiL2Ss_PNw_bMNwCvXWxNyipB49QaKhJeUuO9PNVlYg0rhDKmbzah5nO9WKTZcODWDWmVa5sYDHXZFHhGfuD9HLJ1aZ28u7yi2DUKb1eHFhpbsIMsCaiYmfw6nrEg-7kWYqiVibk-6ESwDNjDVXrPzSjb8EeBtv9vseafKZO_3ZsGd3R0_38_5AHcGwJR8r5HzkO45eo9uNO3pvy5B3dPRj7X7hF8y0xNCwRIS0IKIsViZhLa6JCmIp-O5zPKCBZJYC8KgrxQHtfEe8pVR84x5abxSHU45qe3btk2y55Wvc8ZIy5QWWAd6GM4PZqdfvhIhzYNtJCCLSkXRjo2VUYWNk1tUpZ-T2qt33iXsUeIiB2Xwm_j4oq7JCkLK_0WUlelTEWK0cQT2K6b2j0DwmUpJLPCqakRZVWkjCskALTIu8c5j4CtZZUXA4U5dtL4noerdK7zXr65l28e5JuzCN6Mv7nsCTxunH2IEBhnIvl2eNG0Z_mgy7l0VpmkKGRVepNnWepBrZmsvKlL_C4_jmB_Lfl8sAhdfi32CF6Nw16X8YLG1K5Z9XOUUj4Kj-Bpj7dxJQKjMR8eRqA3kLix1M2R-uI88IVjR3kfVusI3q5Be72uf_8Xz2_-jBewO0U9CuX9-7C9bFfuJdwufiwvunYCW2qhwlNPYOdwNs8-T8J5xwSza7NJUFQ_kh2fZF9-AQxpQNs
linkProvider	ProQuest
linkToHtml	http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1Lb9QwEB6VAgIOPMorUCBIcCpW48SOkwNCPFq1arvqYQ-9WXbi0AqUlOwuqD-K_8iM86iWR289cF17V3b2m_FMPPN9AK9cZE3OK8Gi3Bom0qRkBk95lpWpNbwQyphObEJNJtnRUX64Aj-HXhgqqxx8onfUZVPQO_JNPOeIrSvL0nen3xipRtHt6iCh0cFiz539wJRt9nb3E_6_r-N4e2v6cYf1qgKskILPWSKMdDxWRhY2z21alphCWYt5YhnhhkTkEikw64iqxKVpWViJGU9WlTIXOR1--LNX4Cq6cUUVZOpIja90iGw9E6JvzYmSbHMmvCMiyViJgQJnfOn48yoBfwtt_6zQ_O2a1p9-23f-s-d2F273YXb4vrOLe7Di6jW43glvnq3BrYORrXZ2H74cmpoVBP829AWWjFq1Qy8SFDZVuL872WI8pBYQUtoIifUKrTbEOGAxC4-poKhBO3Q0htNbN2-beUca31XEhc4TdVCX6wOYXsa2H8Jq3dTuMYSJLIXkVjgVG1FWRc4TRfSGllgFkyQJgA_Q0EVP0E46IV-1LxRIMt3BSSOctIeT5gFsjN857ehJLpz9gRA3ziRqcf9B037WvafS0lll0qKQVYkO3fIcTTbjskJHnkaxigJYH4Cme3830-coC-DlOIyeiq6fTO2aRTdHKYU5RgCPOniPKxEUa2LwG0C2BPylpS6P1CfHng0dM2SFSUMWwJvBRs7X9e9n8eTibbyAGzvTg32NCNt7CjdjMmFPZLAOq_N24Z7BteL7_GTWPvc-IAR9ybbzC_hYlFk
linkToPdf	http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1Lb9QwEB6V8hAceJRXoECQ4ATWxokdJweEgHZFVaj20EPFxbITh1agpGx2Qf1p_DtmnEe1PHrrgevau7Kz34xn4pnvA3jmImtyXgkW5dYwkSYlM3jKs6xMreGFUMZ0YhNqby87OMhna_Bz6IWhssrBJ3pHXTYFvSOf4DlHbF1Zlk6qvixitjV9ffyNkYIU3bQOchodRHbdyQ9M39pXO1v4Xz-P4-n2_rv3rFcYYIUUfMESYaTjsTKysHlu07LEdMpazBnLCDcnIpdIgRlIVCUuTcvCSsx-sqqUucjpIMSfvQAXFaaYlPfN5Kfx9Q4Rr2dC9G06UZJNWuGdEsnHSgwaOOMrR6FXDPhbmPtnteZvV7b-JJze-I-f4U243off4ZvOXm7Bmqs34HInyHmyAdc-jiy27W34MjM1K8gs5qEvvGTUwh168aCwqcIPO3vbjIfUGkIKHCGxYaE1hxgfLNvwkAqNGrRPR2M4fe4W82bRkcl3lXKh8wQe1P16B_bPY9t3Yb1uancfwkSWQnIrnIqNKKsi54ki2kNLbINJkgTAB5jooiduJ_2Qr9oXECSZ7qClEVraQ0vzAF6M3znuaEvOnP2W0DfOJMpx_0Ez_6x7D6als8qkRSGrEh295TmacsZlhQ4-jWIVBbA5gE73frDVp4gL4Ok4jB6MrqVM7ZplN0cphblHAPc6qI8rERSDYlAcQLZiBCtLXR2pjw49SzpmzgqTiSyAl4O9nK7r38_iwdnbeAJX0GQ0Amz3IVyNyZo9v8EmrC_mS_cILhXfF0ft_LF3ByHoczadX4_lnUw
openUrl	ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Pan-cancer+multi-omic+model+of+LINE-1+activity+reveals+locus+heterogeneity+of+retrotransposition+efficiency&rft.jtitle=Nature+communications&rft.date=2025-02-28&rft.pub=Nature+Publishing+Group&rft.eissn=2041-1723&rft.volume=16&rft.issue=1&rft.spage=2049&rft_id=info:doi/10.1038%2Fs41467-025-57271-1&rft.externalDBID=HAS_PDF_LINK
thumbnail_l	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2041-1723&client=summon
thumbnail_m	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2041-1723&client=summon
thumbnail_s	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2041-1723&client=summon